Case–control association studies |
|
Mill et al (58) | United Kingdom | 132 | DSM-IV | χ2 | + | OR = 6.2 | 0.01 |
|
Holmes et al (30) | United Kingdom | 129 | ICD-10, DSM-IV and DSM-III-R | χ2 | + | OR = 1.9 | 0.001 |
|
Muglia et al (59) | Canada | 66 | DSM-IV | χ2 | + | OR = 2.5 | 0.01 |
|
Comings et al (60) | United States | 52 | DSM-III-R and DSM-IV | χ2 | + | χ2 = 6.64 | 0.01 |
|
Rowe et al (61) | United States | 70 | DSM-IV | χ2 | + | χ2 = 5.9 | < 0.05 |
|
Swanson et al (62) | United States | 39 | DSM-IV and ICD-10 | χ2 | + | χ2 = 4.65 | < 0.035 |
|
Castellanos et al (63) | United States | 41 | DSM-III-R | χ2 | – | χ2 = 0.06 | 0.81 |
|
La Hoste et al (64) | United States | 39 | DSM-IV | χ2 | + | OR = 3.0 | 95% CI = 1.3–7.1 |
|
Family-based association studies |
Roman et al (28) | Brazil | 81 | DSM-IV | HHRR | – | χ2 = 0.37 | 0.54 |
|
Payton et al (52) | United Kingdom | 103 | ICD-10, DSM-IV and DSM-III-R | TDT | – | N/A | 0.75 |
|
Mill et al (58) | United Kingdom | 85 | DSM-IV | TDT, HHRR | – | N/A | |
|
McCracken et al (65) | United States | 371 | DSM-IV | TDT | + | χ2 = 5.4 | 0.02 |
|
Barr et al (66) | Canada | 82 | DSM-IV | TDT | + | χ2 = 15.68 | < 0.016 |
|
Holmes et al (30) | United Kingdom | 110 | ICD-10, DSM-IV and DSM-III-R | TDT | – | OR = 0.95 | 95% CI = 0.6–1.5 |
|
Kotler et al (67) | Israel | 49 | DSM-IV | HHRR | – | LR = 7.94 | 0.16 |
|
Muglia et al (59) | Canada | 66 | DSM-IV | TDT | + | z = 1.41 | 0.07 |
|
Hawi et al (68) | Ireland | 78 | DSM-IV | HHRR | – | χ2 = 0.00 | 0.95 |
|
Tahir et al (69) | Turkey | 104 | DSM-IV | TDT | + | χ2 = 2.79 | 0.05 |
|
Eisenberg et al (70) | Israel | 49 | DSM-IV | HHRR | – | χ2 = 0.14 | 0.71 |
|
Faraone et al (71) | United States | 54 | DSM-IV | TDT | + | χ2 = 7.4 | 0.007 |
|
Rowe et al (61) | United States | 70 | DSM-IV | TDT | – | χ2 = 0.03 | N/A |
|
Smalley et al (72) | United States | 129 | DSM-III-R and DSM-IV | TDT | + | χ2 = 4.85 | 0.03 |
|
Swanson et al (62) | United States | 52 | DSM-IV | HHRR | + | χ2 = 4.65 | < 0.035 |